Our approach Strategic Pillar Focus • Immunology • Haematology • Nephrology and transplant • Respiratory • Cardiovascular and metabolic • Vaccines • Delivering groundbreaking innovation in areas of unmet need in CSL’s Therapeutic Areas (which you can read more about on page 20) • Driven to meet the needs of patients by leveraging our scientific and clinical expertise to provide the best possible therapies and vaccines Innovation • Products • Delivery • Services • Technology • Yield • Disrupting with cutting edge innovation and a portfolio of products to enhance patient care and public health (for more, see the Innovation section) • Committed to finding innovative approaches to increase yield across core platforms Efficiency & reliable supply • Technology • Operational excellence • Capital project execution • Partnerships • Driving efficiency across the supply chain, from collections through manufacturing and to patients • Striving to maximise value and deliver milestones with key alliances and partnerships Sustainable growth • Plasma protein technology • Recombinant protein technology • Cell & gene therapy • Vaccines technology • Iron therapy • Growing the value of key franchises in plasma, vaccines and iron in a sustainable way by driving market access, using real world evidence and medical capabilities • Continuing to launch key products and indications for CSL’s next phase of growth Digital transformation • Enterprise Value • Worker Productivity • Information Velocity • Building and leveraging data and partnerships to embrace digital transformation across its business • Prioritise opportunities to use AI that drive business value while scaling user‑friendly tools for broad productivity 9
RkJQdWJsaXNoZXIy MjE2NDg3